Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Alfapump (R) implantable device in management of refractory ascites: An update

Abstract : Refractory ascites (RA) is a frequent and life-threatening complication of cirrhosis. In selected patients with RA, transjugular intrahepatic portosystemic shunt (TIPS) placement and liver transplantation (LT) are currently considered the best therapeutic alternatives to repeated large volume paracentesis. In patients with a contraindication to TIPS or LT, the alfapump (R) system (Sequana Medical, Ghent, Belgium) has been developed to reduce the need for iterative. paracentesis, and consequently to improve the quality of life and nutritional status. We report here recent data on technical progress made since the first implantation, the efficacy and tolerance of the device, the position of the pump in the therapeutic arsenal for refractory ascites, and the grey areas that remain to be clarified regarding the optimal selection of patients who are potential candidates for this treatment.
Type de document :
Article dans une revue
Liste complète des métadonnées
Contributeur : Louise DESSAIVRE Connectez-vous pour contacter le contributeur
Soumis le : vendredi 16 septembre 2022 - 11:56:16
Dernière modification le : samedi 17 septembre 2022 - 03:07:01




Delphine Weil-Verhoeven, Vincent Di Martino, Guido Stirnimann, Jean Paul Cervoni, Eric Nguyen-Khac, et al.. Alfapump (R) implantable device in management of refractory ascites: An update. World journal of hepatology, Baishideng Publishing Group Inc, 2022, 14 (7), pp.1344-1356. ⟨10.4254/wjh.v14.i7.1344⟩. ⟨hal-03778924⟩



Consultations de la notice